NDATOPICALCREAM
Approved
Mar 1983
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
BETA-VAL (betamethasone valerate) by Merck & Co. is clinical pharmacology topical corticosteroids share anti-inflammatory, antipruritic and vasoconstrictive actions. First approved in 1983.
Drug data last refreshed 11h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
BETA-VAL (betamethasone valerate) is a topical corticosteroid cream approved by FDA in 1983 for inflammatory and pruritic dermatological conditions. It works through anti-inflammatory, antipruritic, and vasoconstrictive mechanisms, with efficacy correlated to vasoconstrictor potency. The drug is administered topically and represents a mature, established therapeutic option.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), suggesting contracting brand team and focus on cost management and niche positioning.
Mechanism of Action
CLINICAL PHARMACOLOGY Topical corticosteroids share anti-inflammatory, antipruritic and vasoconstrictive actions. The mechanism of anti-inflammatory activity of the topical corticosteroids is unclear. Various laboratory methods, including vasoconstrictor assays, are used to compare and predict…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on BETA-VAL offers limited growth opportunity but provides solid experience in mature brand management, generic defense strategies, and cost-containment initiatives. This role suits professionals seeking stability in a legacy product environment rather than high-growth trajectory roles.
Brand Manager
Worked on BETA-VAL at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.